Chymopapain chemonucleolysis in lumbar disk disease.

Area of Science:

• Neurosurgery
• Orthopedics
• Pain Management

Background:

• Lumbar disk disease is a common cause of debilitating pain.
• Surgical interventions are often considered for severe cases.
• Chemonucleolysis offers a less invasive alternative.

Purpose of the Study:

• To evaluate the efficacy and safety of chymopapain chemonucleolysis for lumbar disk disease.
• To assess complication rates, particularly anaphylaxis.
• To compare long-term outcomes with laminectomy.

Main Methods:

• Retrospective analysis of 1,200 cases undergoing chymopapain chemonucleolysis.
• Inclusion of preoperative corticosteroid and antihistamine administration.
• Long-term follow-up assessment of pain relief and functional outcomes.

Main Results:

• Chymopapain chemonucleolysis demonstrated effectiveness in pain relief for abnormal intervertebral disks.
• Complication rates were low, with anaphylaxis being the most serious.
• Preoperative medication reduced anaphylaxis incidence, though it remained a risk.
• Long-term results were comparable to laminectomy in appropriately selected patients.

Conclusions:

• Chymopapain chemonucleolysis is an effective treatment for lumbar disk disease pain.
• Risk of anaphylaxis necessitates careful patient selection and monitoring.
• The procedure provides comparable long-term outcomes to laminectomy in suitable candidates.